DOPPLER AND IMAGE GUIDED DEVICE FOR NEGATIVE FEEDBACK PHASED ARRAY HIFU TREATMENT OF VASCULARIZED LESIONS

• US 20100160781A1
• Filed: 12/09/2009
• Published: 06/24/2010
• Est. Priority Date: 12/09/2008
• Status: Abandoned Application

• Current Assignee: University of Washington
• Original Assignee: University of Washington
• Inventors: Carter, Stephen, Langer, Steve, Crum, Lawrence, Bailey, Mike, Kucewicz, John, Kaczkowski, Peter
• Application Number:
  US12/634,599
• Publication Number:
  US 20100160781A1
• Time in Patent Office: Days
• US Class Current: 600/439
• CPC Class Codes: A61B 2090/378 using ultrasound
• CPC Class Codes: A61B 8/06 Measuring blood flow measuring volume flow in general G01F, e.g. G01F1/66, G01F1/72; measuring speed of fluids in general G01P5/00
• CPC Class Codes: A61B 8/13 Tomography A61B8/10, A61B8/12 take precedence; tomography for radiation diagnosis A61B6/02
• CPC Class Codes: A61B 8/463 characterised by displaying multiple images or images and diagnostic data on one display composite display in devices for short-range imaging with acoustic waves G01S7/52074
• CPC Class Codes: A61B 8/469 for selection of a region of interest
• CPC Class Codes: A61N 7/02 Localised ultrasound hyperthermia hyperthermia in general A61F7/00

Abstract

A noninvasive technique that can be used to deny blood flow to a particular region of tissue, without the inherent risks associated with invasive procedures such as surgery and minimally-invasive procedures such as embolization. Blood flow in selected portions of the vasculature can be occluded by selectively treating specific portions of the vasculature with high intensity focused ultrasound (HIFU), where the HIFU is targeted Doppler ultrasound data, and a duration of the therapy is automatically controlled using a negative feedback loop provided by Doppler ultrasound data collected during the HIFU therapy. A portion of the vasculature providing blood flow to the undesired tissue is selected by a clinician, or automatically selected based on Doppler data, and HIFU is administered to the selected portion of the vasculature to occlude blood flow through that portion of the vasculature.

Claims

1. A method for using high intensity focused ultrasound (HIFU) to treat undesired tissue by damaging selected vascular regions to affect a viability of the undesired tissue, comprising the steps of:

(a) collecting ultrasound data from the undesired tissue that provides information about flow rates in vascular structures associated with the undesired tissue;

(b) presenting a combined display to a user, where the combined display includes;

(i) an ultrasound image of the undesired tissue and the associated vascular structures;

(ii) the flow rate information; and

(iii) a visualization of a focal point of a HIFU device;

(c) selecting a target site based on the flow rate data and the ultrasound image;

(d) automatically delivering HIFU therapy to the target site;

wherein a duration of the therapy is controlled using a negative feedback loop provided by flow rate information at the target site collected during the HIFU therapy, such that the HIFU therapy is automatically terminated when the flow rate at the target site reaches a predetermined value; and

(e) frequently refreshing the combined display during the HIFU therapy, to enable the user to monitor the progress of the HIFU therapy in real-time.

2. The method of claim 1, wherein the predetermined value represents reducing the flow rate at the target site by at least about 90%.

3. The method of claim 1, wherein the predetermined value corresponds to a background signal associated with the undesired tissue.

4. The method of claim 1, wherein the step of selecting a target site is performed by the user, such that the user determines where the HIFU focal point should be positioned before HIFU therapy is initiated.

5. The method of claim 4, further comprising the step of enabling the user to determine a radius about the HIFU focal point corresponding to a volume to be automatically treated.

6. The method of claim 1, wherein the step of selecting a target site is performed by automatically, by a processor that analyzes the flow rate information to determine where the HIFU focal point should be positioned before HIFU therapy is initiated.

7. The method of claim 6, wherein if there are a plurality of vascular structures associated with the undesired tissue, the step of automatically selecting the target site comprises the step of:

(a) determining flow rate information for each such vascular structure; and

(b) identifying a vascular structure providing a largest flow rate into the undesired tissue as the target site.

8. The method of claim 6, wherein if there are a plurality of vascular structures associated with the undesired tissue, the step of automatically selecting the target site comprises the step of:

(a) determining flow rate information for each such vascular structure;

(b) ignoring each vascular structure corresponding to a flow rate below a predetermined value; and

(c) identifying each vascular structure providing a flow rate into the undesired tissue above a predetermined value as the target site, such that HIFU therapy is automatically performed at each target site so identified.

9. The method of claim 1, wherein the step of selecting a target site comprises the steps of:

(a) enabling the user to define a region of interest (ROI), where tissue within the ROI can be treated with HIFU without substantially damaging non-target tissue; and

(b) automatically selecting a target site within the region of interest, using a processor that analyzes the flow rate information to determine where the HIFU focal point should be positioned before HIFU therapy is initiated, that position corresponding to the target site.

10. The method of claim 1, wherein the step of presenting the combined display to the user further comprises displaying a relative HIFU dose during the HIFU therapy.

11. The method of claim 1, wherein the step of presenting the combined display to the user further comprises displaying a status of the HIFU beam, to enable the user to determine if the HIFU beam is energized.

12. A method for using high intensity focused ultrasound (HIFU) to treat undesired tissue by damaging selected vascular regions to affect a viability of the undesired tissue, comprising the steps of:

(a) collecting ultrasound data from the undesired tissue that provides information about flow rates in vascular structures associated with the undesired tissue;

(b) presenting a combined display to a user, where the combined display includes;

(i) an ultrasound image of the undesired tissue and the associated vascular structures;

(ii) the flow rate information; and

(iii) a visualization of a focal point of a HIFU device;

(c) selecting a target site based on the flow rate data and the ultrasound image; and

(d) automatically delivering HIFU therapy to the target site;

wherein a duration of the therapy is controlled using a negative feedback loop provided by flow rate information at the target site collected during the HIFU therapy, such that the HIFU therapy is automatically terminated when the flow rate at the target site reaches a predetermined value.

13. A system for using high intensity focused ultrasound (HIFU) to treat undesired tissue by damaging selected vascular regions to affect a viability of the undesired tissue, comprising:

(a) an imaging ultrasound component for collecting ultrasound data from the undesired tissue to provide information about flow rates in vascular structures associated with the undesired tissue and an ultrasound image;

(b) a HIFU therapy component for delivering HIFU therapy to a target site;

(c) a user interface enabling a user to interact with the system;

(d) a display component for providing information to a user; and

(e) a controller implementing the following functions;

(i) generating a combined display on the display component, the combined display including an ultrasound image of the undesired tissue and the associated vascular structures, the flow rate information; and

a visualization of a focal point of a HIFU device;

(ii) automatically selecting a target site based on the flow rate data and a user defined region of interest; and

(iii) automatically delivering HIFU therapy to the target site;

wherein a duration of the therapy is controlled using a negative feedback loop provided by flow rate information at the target site collected during the HIFU therapy, such that the HIFU therapy is automatically terminated when the flow rate at the target site reaches a predetermined value.

14. The system of claim 13, wherein the controller automatically selects the target by:

(a) determining flow rate information for each vascular structure associated with the region of interest;

(b) ignoring each vascular structure corresponding to a flow rate below a predetermined value; and

(c) identifying each vascular structure providing a flow rate into the undesired tissue above a predetermined value as the target site, such that HIFU therapy is automatically performed at each target site so identified.

15. The system of claim 13, wherein the controller automatically selects the target by:

(a) determining flow rate information for each vascular structure associated with the region of interest; and

(b) identifying a vascular structure providing a largest flow rate into the undesired tissue as the target site.